Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice

Curr Cardiol Rev. 2021;17(5):e160721187934. doi: 10.2174/1573403X16666201113093548.

Abstract

At least half of all heart failure (CHF) patients will have a comorbidity that could be undertreated, requires additional speciality input and/or polypharmacy. These patients are then at risk of iatrogenic and disease-related complications and readmissions if not closely supervised. Common comorbidities of relevance are cardiorenal and cardiometabolic syndromes (DM, obesity, OSA), chronic airways disease, elderly age, and accompanying pharmacotherapies. The structure of community practice often leaves primary, speciality, and allied health care in silos. For example, cardiology speciality training in Australia creates excellent sub-specialists to deliver diagnostic and therapeutic advances. A casualty of this process has been the gradual alienation of general cardiology toward general internal medical specialists and primary care practitioners. The consequences are largely noticed in community practice. The issue is compounded by suboptimal communication of information. This review explores these issues from a cardiology sub-speciality lens; firstly cross speciality areas that are important for cardiologists to maintain their skill, and finally, to obtain a brief overview of disease management and identify game-changing common denominators such as endothelial dysfunction and self-management.

Keywords: Comorbidity; cardiometabolic syndrome.; cardiovascular disease; congestive heart failure; disease management; metabolically healthy obesity; obesity; obesity paradox; performance markers; process of care; specialist training.

Publication types

  • Review

MeSH terms

  • Aged
  • Australia
  • Cardiology*
  • Comorbidity
  • Heart Failure* / epidemiology
  • Heart Failure* / therapy
  • Humans
  • Prognosis